News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AllCells, LLC Announces Plans to Relocate and Expand U.S Operations


12/14/2012 8:16:11 AM

EMERYVILLE, Calif., Dec. 13, 2012 /PRNewswire/ -- AllCells LLC, a leading life science industry provider of human hematologic tissue such as bone marrow, Leuko Paks, peripheral blood, healthy & diseased primary cells, and cell-based assay services, today announced plans to relocate its U.S operations to Alameda, California. The relocation will occur towards the end of Q1, 2013.

Located at 1301 Harbor Bay Parkway, Alameda, CA, the new headquarters and production facility comprises approximately 30,000 square feet of leased space, which will add approximately 70% more operational space compared to the company's current location in Emeryville.

"The integration of clinical tissue collection and manufacturing operations into a single space will have significant impact on streamlining our process work-flow and improve manufacturing efficiency", stated Jay Tong, M.D, President and CEO. "The larger space provides substantially more production capacity to meet the increased market demand for our products and bioservices."

The company also maintains approximately 10,000 square feet of operations located in Ju Ke Biotechnology Park, Shanghai, China, near the center of the city.

About AllCells, LLC
AllCells (www.AllCells.com) is a global biotechnology company founded in 1998 to provide researchers with a reliable supply of biologically relevant, consistent quality primary cells (healthy & diseased) which enable the advancement of scientific research in the areas of cell biology, oncology, virology, hematology, infectious disease and stem cell research. Unlike cell lines, which are typically mutated, transformed or immortalized, primary cells retain their original phenotypes hence better reflect in vivo morphology, metabolism and growth characteristics. These attributes are especially important for in vitro research applications in which in vivo-like models are critically important. By partnering with AllCells, investigators can dramatically reduce the time needed to isolate cells with guaranteed consistency, thereby improving the efficiency, accuracy and relevance of their research studies. AllCells is fully certified in accordance with local, state and federal requirements.

SOURCE AllCells, LLC


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES